home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

3-Hour Virtual Seminar on FDA's Scrutiny of Social Media Promotion

 
  January 16, 2019  
     
 
Netzealous LLC DBA - Compliance4All, Online
03/12/2019


Overview:
In this webinar you will Learn how to navigate through FDA requirements, Ways to manage your presence in social media, How to identify an off-label problem and corrective action.

Why should you Attend:
Limitations on commercial free speech
Avenues of off-label information
Social media and your regulatory responsibilities
Correcting off-label information
Factoring in cognitive psychology

Areas Covered in the Session:
Learn to navigate through FDA requirements
Understand that your right to free speech is limited
How to get around FDA prohibitions
Ways to manage your presence in social media

Who Will Benefit:
Regulatory Directors
Marketing Directors
Quality Systems Auditors
Recall Managers
In-house Legal Counsel

Event Fee: One Dial-in One Attendee Price: US$290.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: compliance4all14@gmail.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Casper (Cap) Uldriks, through his firm “Encore Insight LLC,” brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.
 
Deadline for Abstracts: 03/11/2019
 
Registration: https://www.compliance4all.com/control/w_product/~product_id=502335LIVE?channel=hum-molgen_Mar_2019_SEO
E-mail: compliance4all14@gmail.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.